BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zhang Y, Zhou JH, Yin XL, Wang FY. Treatment of hepatitis B virus-associated glomerulonephritis: A meta-analysis. World J Gastroenterol 2010; 16(6): 770-777 [PMID: 20135728 DOI: 10.3748/wjg.v16.i6.770]
URL: https://www.wjgnet.com/1007-9327/full/v16/i6/770.htm
Number Citing Articles
1
M. Khalighi, A. Chang. Pathobiology of Human Disease2014; : 2857 doi: 10.1016/B978-0-12-386456-7.05413-7
2
Jeong-Ju Yoo, Jeong-Hoon Lee, Jung-Hwan Yoon, Minjong Lee, Dong Hyeon Lee, Yuri Cho, Eun Sun Jang, Eun Ju Cho, Su Jong Yu, Yoon Jun Kim, Hyo-Suk Lee. Hepatitis B Virus-Related Glomerulonephritis: Not a Predominant Cause of Proteinuria in Korean Patients with Chronic Hepatitis BGastroenterology Research and Practice 2015; 2015: 1 doi: 10.1155/2015/126532
3
T. A. Ladapo, E. U. Onifade, A. E. Lesi, O. A. Lesi. Successful Treatment of Hepatitis B Virus Associated Nephrotic Syndrome With Oral Lamivudine in a Nigerian Child: A Case ReportJournal of Tropical Pediatrics 2012; 58(2): 157 doi: 10.1093/tropej/fmr046
4
Jasmine Riviere Marcelin, Lynda A. Szczech, Stacey Rizza. Core Concepts in Parenchymal Kidney Disease2014; : 209 doi: 10.1007/978-1-4614-8166-9_13
5
Yue Yang, Ye-ping Ma, Da-peng Chen, Li Zhuo, Wen-ge Li, Anna Kramvis. A Meta-Analysis of Antiviral Therapy for Hepatitis B Virus-Associated Membranous NephropathyPLOS ONE 2016; 11(9): e0160437 doi: 10.1371/journal.pone.0160437
6
Hitesh H. Shah, Chinmay Patel, Kenar D. Jhaveri. Complete Remission of Hepatitis B Virus-Associated Nephrotic Syndrome from IgA Nephropathy Following Peginterferon TherapyRenal Failure 2013; 35(2): 295 doi: 10.3109/0886022X.2012.745785
7
Zhaoping Yan, Bing Qiao, Haifeng Zhang, Yanling Wang, Wei Gou. Effectiveness of telbivudine antiviral treatment in patients with hepatitis B virus-associated glomerulonephritisMedicine 2018; 97(31): e11716 doi: 10.1097/MD.0000000000011716
8
Fabrizio Fabrizi, Roberta Cerutti, Ezequiel Ridruejo. Hepatitis B virus infection as a risk factor for chronic kidney diseaseExpert Review of Clinical Pharmacology 2019; 12(9): 867 doi: 10.1080/17512433.2019.1657828
9
Jing Fang, Wenge Li, Zhao Tan, Duo Li. Comparison of prednisolone and lamivudine combined therapy with prednisolone monotherapy on carriers of hepatitis B virus with IgA nephropathy: a prospective cohort studyInternational Urology and Nephrology 2014; 46(1): 49 doi: 10.1007/s11255-013-0480-5
10
Chrysoula L. Pipili, George V. Papatheodoridis, Evangelos C. Cholongitas. Treatment of hepatitis B in patients with chronic kidney diseaseKidney International 2013; 84(5): 880 doi: 10.1038/ki.2013.249
11
Andres F. Carrion, Paul Martin. Prevention and Management of HBV Infection in Patients with Chronic Kidney Disease Requiring Renal TransplantationCurrent Hepatology Reports 2018; 17(4): 485 doi: 10.1007/s11901-018-0438-2
12
Brad H. Rovin, Sharon G. Adler, Jonathan Barratt, Frank Bridoux, Kelly A. Burdge, Tak Mao Chan, H. Terence Cook, Fernando C. Fervenza, Keisha L. Gibson, Richard J. Glassock, David R.W. Jayne, Vivekanand Jha, Adrian Liew, Zhi-Hong Liu, Juan Manuel Mejía-Vilet, Carla M. Nester, Jai Radhakrishnan, Elizabeth M. Rave, Heather N. Reich, Pierre Ronco, Jan-Stephan F. Sanders, Sanjeev Sethi, Yusuke Suzuki, Sydney C.W. Tang, Vladimir Tesar, Marina Vivarelli, Jack F.M. Wetzels, Jürgen Floege. KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular DiseasesKidney International 2021; 100(4): S1 doi: 10.1016/j.kint.2021.05.021
13
Gaosi Xu, Tianlun Huang. Hepatitis B virus-associated glomerular nephritis in East Asia: Progress and challengesEuropean Journal of Internal Medicine 2011; 22(2): 161 doi: 10.1016/j.ejim.2010.11.005
14
Rohan Malik, Winita Hardikar. Hepatitis B and C in ChildrenThe Indian Journal of Pediatrics 2016; 83(11): 1303 doi: 10.1007/s12098-016-2076-4
15
Shan Mou, Jialin Li, Zanzhe Yu, Qin Wang, Zhaohui Ni. Keto acid-supplemented low-protein diet for treatment of adult patients with hepatitis B virus infection and chronic glomerulonephritisJournal of International Medical Research 2013; 41(1): 129 doi: 10.1177/0300060512474758
16
Ting Liu, Shicong Yang, Zhihui Yue, Yu Kuang, Weiming Guan, Liangzhong Sun. Clinical and pathological characteristics of 5 children with HBV surface antigen (HBsAg)-negative hepatitis B virus-associated glomerulonephritisJournal of Clinical Virology 2015; 66: 1 doi: 10.1016/j.jcv.2015.02.012
17
Chiao-Wei Huang, Cheng-Heng Lin, Ya-Wen Chuang, Sheng-Shun Yang, Teng-Yu Lee, Hong-Zen Yeh, Chi-Sen Chang, I-Ta Lu. Association of hepatitis B virus infection and glomerulonephritis in a HBV-endemic area: A population-based studyAdvances in Digestive Medicine 2018; 5(4): 121 doi: 10.1002/aid2.13092
18
Cui Li Lin, Chelsea Q. Xu, Jack R. Wands. Viral Hepatitis2013; : 451 doi: 10.1002/9781118637272.ch33
19
Yi-Chun Chen, Chung-Yi Li, Shiang-Jiun Tsai, Yen-Chun Chen. Nationwide cohort study suggests that nucleos(t)ide analogue therapy decreases dialysis risk in Taiwanese chronic kidney disease patients acquiring hepatitis B virus infectionWorld Journal of Gastroenterology 2018; 24(8): 917-928 doi: 10.3748/wjg.v24.i8.917
20
Baohui Fu, Yue Ji, Shouci Hu, Tong Ren, Maheshkumar Satishkumar Bhuva, Ge Li, Hongtao Yang, Heidar Sharafi. Efficacy and safety of anti-viral therapy for Hepatitis B virus-associated glomerulonephritis: A meta-analysisPLOS ONE 2020; 15(1): e0227532 doi: 10.1371/journal.pone.0227532
21
Tao Peng, Tingting Xie, Lei Liu, Junhui Zhen, Xiangdong Yang. Analysis of clinical features and pathology of serum HBsAg positive glomerulonephritisJournal of Medical Virology 2018; 90(3): 612 doi: 10.1002/jmv.24959